Carbobenzoxyproline
CAS No. 1148-11-4
Carbobenzoxyproline( Benzyloxycarbonylproline,Carbobenzoxy-S-proline )
Catalog No. M22867 CAS No. 1148-11-4
Carbobenzoxyproline is a prolidase inhibitor.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 500MG | 35 | In Stock |
|
| 1G | 46 | In Stock |
|
Biological Information
-
Product NameCarbobenzoxyproline
-
NoteResearch use only, not for human use.
-
Brief DescriptionCarbobenzoxyproline is a prolidase inhibitor.
-
DescriptionCarbobenzoxyproline is a prolidase inhibitor.
-
In VitroCarbobenzoxyproline (6 mM; 0-10 d; pH=6.0) causes mitochondrial depolarization and increases cellular death by 33% as reported for long-term culture of fibroblasts from prolidase deficiency (PD) patients. Carbobenzoxyproline (0, 1, 3, 6 mM; 1 min; pH=6.0) results fibroblasts prolidase (FBP) hydrolysis, shows linear competitive inhibition.
-
In VivoCarbobenzoxyproline (60 mg/kg; injection; once daily; 3 weeks) serves as in vivo inhibitor of erythrocytes prolidase in mice model. Animal Model:C57Bl/6J mice (4-week-old)Dosage:60 mg/kg Administration:Injection; once daily for 3 weeks Result:Resulted significant reduction of erythrocytes prolidase activity.
-
SynonymsBenzyloxycarbonylproline,Carbobenzoxy-S-proline
-
PathwayOthers
-
TargetOther Targets
-
Recptorprolidase
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1148-11-4
-
Formula Weight249.26
-
Molecular FormulaC13H15NO4
-
Purity>98% (HPLC)
-
SolubilityDMSO:Soluble
-
SMILESC1CC(N(C1)C(=O)OCC2=CC=CC=C2)C(=O)O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Arkadiusz, Surazynski, and, et al. Prolidase-dependent regulation of TGF c and TGF β receptor expressions in human skin fibroblasts[J]. European Journal of Pharmacology, 2010, 649(1-3):115-119.
molnova catalog
related products
-
TC-O 9311
TC-O 9311 is a potent GPR139 agonist.
-
Siplizumab
Siplizumab (MEDI-507) is a humanized IgG1 monoclonal antibody that targets CD2, selectively depleting effector memory T cells and promoting the relative expansion of alloreactive regulatory T cells in vitro. Siplizumab can be used to treat plaque psoriasis.
-
α-MSH
α-MSH
Cart
sales@molnova.com